✦ LIBER ✦

Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation to Treat Patients with Poor-Risk, Relapsed, or Refractory Multiple Myeloma

✍ Scribed by George E. Georges; Michael B. Maris; David G. Maloney; Brenda M. Sandmaier; Mohamed L. Sorror; Judith A. Shizuru; Thoralf Lange; Edward D. Agura; Benedetto Bruno; Peter A. McSweeney; Michael A. Pulsipher; Thomas R. Chauncey; Marco Mielcarek; Barry E. Storer; Rainer Storb

Book ID: 116279169
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 188 KB
Volume: 13
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.11.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unrelated donor hematopoietic cell trans

✍ G.E. Georges; M.B. Maris; B.M. Sandmaier; M.J. Stuart; D. Niederwieser; E. Agura 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Nonmyeloablative unrelated donor (URD) h

Nonmyeloablative unrelated donor (URD) hematopoietic cell transplantation (HCT) for the treatment of patients (PTS) with poor-risk, relapsed or refractory multiple myeloma

✍ G.E. Georges; M.B. Maris; D.G. Maloney; B.M. Sandmaier; M.L. Sorror; J.A. Shizur 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Comparable outcomes between unrelated an

Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma

✍ Jean El-Cheikh; Roberto Crocchiolo; Jean-Marie Boher; Sabine Furst; Anne-Marie S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Treatment of patients (pts) with chemoth

Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)

✍ M.L. Sorror; M.B. Maris; B.M. Sandmaier; M. Jain-Stuart; B. Storer; U. Hegenbart 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A Pilot Study of T-Cell Depleted Allogen

A Pilot Study of T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation With Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients With Relapsed Multiple Myeloma and High-Risk Cytogenetics

✍ G. Koehne; H. Landau; H. Hassoun; A. Lesokhin; N. Lendvai; M. Rosenzweig; D.J. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB